(AND IN REAL LIFE)
WITH ACKNOWLEDGMENT TO DR. BARBARA PHILIPS FOR SLIDE
CONTENT
1870’s - First descriptions of narcolepsy/ cataplexy
1920’s - Description of post encephalitic narcolepsy
1950’s - Treatment with methylphenidate; description of
the tetrad; description of idiopathic hypersomnia
1960’s - Use of TCA’s for cataplexy; discovery of
SOREM’s; first reports of OSA
1970’s - Consensus definition of narcolepsy; first
sleep nosology
1990 - International Classification of Sleep Disorders
(ICSD)
The Narcolepsy “Tetrad” Excessive daytime sleepiness (EDS)
Cataplexy
Hypnogogic hallucinations
Sleep paralysis
(Disrupted nocturnal sleep)
Excessive Daytime Sleepiness
Sleep attacks” are neither sensitive nor specific markers of narcolepsy
EDS is the sine qua non of narcolepsy
“monosymptomatic” narcolepsy
Sleepiness of narcolepsy is no different from other kinds of sleepiness
Cataplexy Episodic (bilateral) weakness without altered
consciousness lasting seconds to minutes and precipitated by excitement or emotion
May occur several times/day or a few times/year
Sagging of face, eyelid, or jaw; dysarthria; head drop; blurred vision; knee buckling; “drop attack”
Laughter is most common precipitator
Usually develops within a few months of EDS symptoms, but may develop 10-30 years later
6
Hypnogogic Hallucinations Vivid, “waking dreams” that occur during
transitions between sleep and wakefulness
Hypnogogic @ sleep onset
Hypnopompic @ awakening
May accompany sleep paralysis or occur independently
Neither sleep paralysis nor hypnagogic hallucinations are specific for narcolepsy
7
Making the Diagnosis History
Physical examination
Specific testing
Measuring Sleepiness Subjective scales
Stanford sleepiness scale
Epworth sleepiness scale
Objective testing
Multiple sleep latency testing (MSLT)
Maintenance of wakefulness test (MWT)
9
In-Lab Testing for Narcolepsy Polysomnography (PSG)
Multiple Sleep Latency Testing (MSLT)
10
MSLT Protocol Drug testing advisable (urine drug screen)
Should follow an overnight PSG
4 or 5 naps, 2 hours apart
naps last 20 minutes, or 15 minutes after onset of sleep (longest can be 35 mins)
unit of measure:
minutes to sleep onset (stage 1)
minutes to REM sleep onset (beginning with stage 1)
11
MSLT Findings
Mean sleep latency
Normal is > 10 minutes
8.5-10 minutes is “gray zone”
<8.5 minutes is pathological sleepiness
REM-onset sleep periods
Normal is < 2
If there is only one, it is most likely to be in first nap
One SOREMP obligates you to 5th nap or second SOREMP
Patient #3 26 Y.O. female
Chronic excessive daytime sleepiness
Multiple awakenings
(+)cataplexy, sleep paralysis, hypnagogic
hallucinations
History of hyperparathyroidism
15
Epidemiology of Narcolepsy M=F
1/10,000 1/2000 1/200?
Prevalence varies with ethnicity
1/600 in Japan
1/4000 in North America and Europe
1/500,000 in Israel
Symptoms usually appear in in teens or 20’s, but diagnosis may be delayed by decades.
16
Pathophysiology Sleep-onset REM accounts for associated
symptoms (intrusion of REM atonia)
Impaired sleep/wake regulation is the primary problem
Autoimmune-mediated neuronal damage?
17
Dysfunction of the hpocretin (AKA orexin) peptide system is associated with narcolepsy in dogs and in mice
Hypocretins affect gamma amino butyric acid (GABA) and glutamate secretion
Hypocretins also have a role in appetite stimulation
So what?
Genetics
HLA testing – useful?
DQB1-0602 subtype is most strongly associated with narcolepsy (90% in Caucasians)
Children of narcoleptics have 1% risk.
19
Differential Diagnosis of EDS Sleep deprivation
Another sleep disorder (OSA, RLS)
Poor sleep quality due to illness (CHF)
Medications, drugs, toxins
Depression
Delayed sleep-phase syndrome
Idiopathic hypersomnia
20
Comparison of Narcolepsy and IH Narcolepsy Sleepiness
Naps are frequent and restorative
Cataplexy(+/-)
Disrupted nocturnal sleep
Associated symptoms
Never remits
IH Prolonged or deep
sleep Naps n0n-restorative
No cataplexy
Reports of remission
May follow viral infection, head trauma
Other associated symptoms/signs
Periodic limb movements of sleep are frequently seen on PSG in narcoleptics (as they are in all patients, in general). RLS symptoms are rare.
REM behavior disorder occurs frequently in narcoleptics, and is not associated with increased risk of developing Parkinson’s or other neurologic disorders.
Problems with MSLT
Circadian rhythm
Effects of medications
P atient anxiety
Frequent false negatives, even in patients with cataplexy
Patient #1 31 Y.O. male
EDS since mononucleosis at age 18
Has been told he snores loudly
Possible sleep paralysis and hypnagogic
hallucinations
Also has episodes of onset and maintenance
insomnia, multiple awakenings
AHI TST: 2.9
RDI: 17.4/hr.
Total Sleep Time: 8.5 hrs.
Sleep Efficiency: 90%
REM: 22%
AHI REM: 3.7
Sleep Onset: 6.0 min.
REM latency: 94 minutes
Total Number of PLMS: 0
Sleep logs indicated an average of 8.75 hours of sleep per night for previous week. Bedtimes varied between 10:00 pm and 2:00 am, with wake times between 8:00 am and 10:00 am. (18 months after diagnosis, patient reports episodes of muscle weakness triggered by strong emotion)
There was one sleep onset REM period in Nap 2 with two epochs of REM
Number of Naps 5 Number of Naps with sleep 5 Number of Naps with REM 1 Nap 1 Nap 2 Nap 3 Nap 4 Nap 5 Mean
Lights Out 10:58 AM 1:06 PM 3:06 PM 5:14 PM 7:04 PM ---
Sleep Onset 11:06 AM 1:13 PM 3:12 PM 5:22 PM 7:15 PM ---
Lights On 11:22 AM 1:29 PM 3:29 PM 5:39 PM 7:31 PM ---
Time In Bed 24.0 min. 22.5 min. 23.0 min. 24.5 min. 27.5 min. 24.3 min.
Sleep Time 13.5 min. 14.0 min. 16.5 min. 12.0 min. 13.5 min. 13.9 min.
Sleep Latency 8.5 min. 7.0 min. 6.0 min. 8.0 min. 11.0 min. 8.1 min.
REM Latency --- 9.5 min. --- --- --- 9.5 min.
TREAT THE PATIENT, NOT THE TEST!
• Narcolepsy is ultimately a clinical diagnosis.
• The diagnosis of narcolepsy CANNOT be ruled out by sleep studies alone
• Most patients with a diagnosis of idiopathic hypersomnia have narcolepsy.
• Many narcoleptics are inaccurately diagnosed with chronic fatigue syndrome or fibromyalgia.
• While narcolepsy and depression often coexist, depression is probably over-diagnosed in narcoleptics, diagnosed and undiagnosed.
*opinion
Sleep Academic Award 29
Management of Narcolepsy Patient and family education
Sleep hygiene
Napping
Safety issues
Medications
Sleep Academic Award 30
Drug Treatment for Narcolepsy EDS-stimulants
Amphetamines, Modafinil, Desmodafinil, others
REM-associated phenomena-TCA’s, SSRIs, other REM-suppressing antidepressants.
Sodium Oxybate (Xyrem) – cataplexy AND EDS
31
Drug Therapy Issues
Abuse (not!)
Compliance
Drug holidays
Patient #2 19 Y.O. female college student
Severe excessive daytime sleepiness beginning 7 months before referral
No cataplexy, etc.
Less sleepy if she sleeps 10 hours/night